Britain’s Circassia has secured the U.S. rights from AstraZeneca for two drugs to treat chronic obstructive pulmonary disease (COPD), a progressive lung condition affecting millions of people, for up to $230 million.
In what feels a bit like a self-fulfilling prophecy, two analyst firms downgraded Biogen, causing the stock to drop.
Shares of Threshold Pharmaceuticals shot up more than 43 percent this morning after the company announced it was merging with Austin, Texas-based Molecular Templates Inc. and receiving an infusion of millions of dollars in financing.
The U.S. Food and Drug Administration gave AstraZeneca’s New Drug Application for ZS-9 (sodium zirconium cyclosiliate) a Complete Response Letter (CRL) — again. The drug was being developed for hyperkalemia by ZS Pharma, a wholly owned subsidiary of AstraZeneca.
Get thesis – completely unique job It takes much time to check out the certain matter and find out the needful results. Study paper requirements plenty of expertise to make a good one. This write is creating within the last season of examine and yes it demonstrates all your expertise and abilities.
PTC Therapeutics Inc. said on Thursday it would buy Marathon Pharmaceuticals LLC’s recently approved Duchenne muscular dystrophy drug, Emflaza, and promised to re-examine the hefty U.S. price tag on the treatment.
★Edu★ Your Optimal Success Guide For Research Paper Writing The land of the rising sun has given rise to so many technology related developments that it is really next to impossible to keep pace with. The rates charged should be reasonable in that they reflect the quality of papers.
Israel’s MedyMatch Technology said on Thursday IBM Watson Health would integrate MedyMatch’s technology into its offerings to imaging experts in hospitals to help doctors identify intracranial bleeding from head trauma and stroke.
Federal spending on health and human services takes a major blow under the first federal spending plan proposed by President Donald Trump.